megestrol has been researched along with methotrexate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Foitl, DR; Hyman, G; Lefkowitch, JH | 1 |
| Cohen, SC; Gregory, EJ; Mims, CH; Oines, DW | 1 |
1 review(s) available for megestrol and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for megestrol and methotrexate
| Article | Year |
|---|---|
Jaundice and intrahepatic cholestasis following high-dose megestrol acetate for breast cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Breast Neoplasms; Cholestasis, Intrahepatic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Jaundice; Mastectomy, Radical; Megestrol; Megestrol Acetate; Methotrexate; Prednisone; Vincristine | 1989 |
Megestrol acetate therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Methotrexate; Receptors, Estrogen; Receptors, Progesterone | 1985 |